erlotinib hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
20 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
Armas Pharmaceuticals Inc.
Aurobindo Pharma Limited
AX Pharmaceutical Corp
Camber Pharmaceuticals, Inc.
Cambrex Charles City, Inc
Cipla Ltd.
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
Hetero Labs Limited
MSN Laboratories Private Limited
Natco Pharma Limited
Novadoz Pharmaceuticals LLC
SHILPA PHARMA LIFESCIENCES LIMITED
Sichuan Xieli Pharmaceutical Co., Ltd.
Sicor de Mexico S.A. de C.V
Teva Pharmaceuticals USA, Inc.
VALARY LAB LIMITED
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Erlotinib Hydrochloride
- •Erlotinib
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS183319-69-9
PubChem CID176871
DTXSIDDTXSID10171412
FormulaC22H24ClN3O4
Mol. Weight429.9 g/mol
SMILESCOCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl
Data Sources
1768712026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/erlotinib hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/erlotinib hydrochloride.json
CAS 183319-69-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json